5-HT4 Receptor Protein

5-HT4 Receptor Protein

Overview

The 5-HT4 receptor (also designated HTR4 or 5-hydroxytryptamine 4 receptor) is a G-protein coupled receptor (GPCR) that belongs to the serotonergic neurotransmitter receptor family. This seven-transmembrane domain protein is encoded by the HTR4 gene located on chromosome 5q31-q32 in humans. The 5-HT4 receptor exists in multiple isoforms generated through alternative splicing, with the most studied variants being the short (a) and long (b) forms that differ in their intracellular C-terminal regions. These receptors are widely distributed throughout the central and peripheral nervous systems, with particularly high expression in the hippocampus, prefrontal cortex, striatum, and gastrointestinal tract. The 5-HT4 receptor is positively coupled to adenylyl cyclase through Gs proteins, leading to increased intracellular cyclic adenosine monophosphate (cAMP) levels and downstream signaling cascade activation.

Function and Biology

5-HT4 Receptor Protein

Overview

The 5-HT4 receptor (also designated HTR4 or 5-hydroxytryptamine 4 receptor) is a G-protein coupled receptor (GPCR) that belongs to the serotonergic neurotransmitter receptor family. This seven-transmembrane domain protein is encoded by the HTR4 gene located on chromosome 5q31-q32 in humans. The 5-HT4 receptor exists in multiple isoforms generated through alternative splicing, with the most studied variants being the short (a) and long (b) forms that differ in their intracellular C-terminal regions. These receptors are widely distributed throughout the central and peripheral nervous systems, with particularly high expression in the hippocampus, prefrontal cortex, striatum, and gastrointestinal tract. The 5-HT4 receptor is positively coupled to adenylyl cyclase through Gs proteins, leading to increased intracellular cyclic adenosine monophosphate (cAMP) levels and downstream signaling cascade activation.

Function and Biology

The 5-HT4 receptor mediates multiple physiological functions through ligand-binding to serotonin (5-hydroxytryptamine or 5-HT) in the synaptic cleft. Upon serotonin binding, the receptor undergoes conformational changes that activate heterotrimeric G-proteins, particularly the stimulatory Gs subtype. This activation triggers adenylyl cyclase stimulation and cAMP production, which subsequently activates protein kinase A (PKA) and other downstream effectors including phosphodiesterase enzymes and ion channels. In the brain, 5-HT4 receptor activation modulates neuronal excitability and influences synaptic plasticity through phosphorylation of various substrates. The receptor also exhibits coupling to phospholipase C pathways and can modulate calcium signaling. In the hippocampus, 5-HT4 activation facilitates long-term potentiation (LTP), a cellular mechanism underlying learning and memory formation. Peripheral 5-HT4 receptors regulate gastrointestinal motility and secretion through enteric neuron modulation, explaining the clinical utility of 5-HT4 agonists in treating motility disorders.

Role in Neurodegeneration

Emerging evidence indicates that 5-HT4 receptor dysfunction contributes to pathological mechanisms in several neurodegenerative diseases. In Alzheimer's disease (AD), 5-HT4 receptors regulate amyloid-beta (Aβ) processing through modulation of alpha-secretase activity and non-amyloidogenic pathway enhancement. Activation of hippocampal 5-HT4 receptors promotes soluble amyloid precursor protein alpha (sAPPα) release while reducing amyloid-beta production. Furthermore, 5-HT4 receptor signaling positively influences tau metabolism and may reduce tau phosphorylation through PKA-mediated pathways. In Parkinson's disease, serotonergic dysfunction including altered 5-HT4 signaling contributes to motor symptoms and potentially to the accumulation of alpha-synuclein. The receptor's role in neuroinflammation appears relevant, as 5-HT4 activation can modulate microglial responses and reduce pro-inflammatory cytokine production. Additionally, 5-HT4 signaling enhances synaptic plasticity and neuroprotection through cAMP-dependent mechanisms that may counteract neurodegeneration-associated synaptic dysfunction.

Molecular Mechanisms

The neuroprotective mechanisms of 5-HT4 receptor activation involve multiple interconnected pathways. Gs-coupled cAMP signaling activates PKA, which phosphorylates the cAMP response element binding protein (CREB) and enhances neurotrophic gene expression. The receptor's stimulation of cAMP also activates exchange proteins directly activated by cAMP (EPAC), promoting neuronal survival and dendritic growth. 5-HT4 receptors participate in regulation of amyloid precursor protein (APP) processing through phosphorylation-dependent mechanisms affecting secretase activity. The receptor can modulate N-methyl-D-aspartate (NMDA) receptor function and calcium homeostasis, critical for preventing excitotoxic neuronal death. Cross-talk with brain-derived neurotrophic factor (BDNF) signaling pathways enhances neurotrophic support and synaptic stabilization.

Clinical and Research Significance

5-HT4 receptor agonists have become promising therapeutic targets in Alzheimer's disease research due to their potential to reduce amyloid-beta pathology and enhance cognitive function. Compounds like RS67333 and prucalopride have demonstrated neuroprotective effects in preclinical models. Clinical trials investigating 5-HT4 agonists for AD cognitive symptoms are ongoing, reflecting therapeutic potential beyond traditional symptomatic treatments.

Related Entities

Related serotonergic receptors include 5-HT1A, 5-HT6, and 5-HT7 receptors, which show overlapping but distinct roles in cognition and neuroprotection